Burns: would tilapia skin be a more economical and effective alternative for the SUS compared to traditional treatment?

• Autor(a) principal: Pereira da Cruz, Gean
• Data de Publicação: 2023
• Outros Autores: Teixeira de Andrade , Fernanda, Duarte Silva, Jules Brendo, Vilas Boas Bento, Pedro José, Soares Negrão, Frank, Oliveira Silva Pereira, Vanesssa, da Silva, Liliane Cristina, Goulart Alves, Mateus
• Tipo de documento: Artigo
• Idioma: por
• Título da fonte: Interfaces Científicas. Saúde e Ambiente (Online)
• Texto Completo: https://periodicos.set.edu.br/saude/article/view/11361

A large number of burns are treated every single year in the Brazilian public healthcare system, known as SUS, being treated mainly with silver sulfadiazine cream. More recent studies, however, draw attention to the prominence of biological dressings, especially xenografts in the treatment of burns. Nile tilapia skin recently became the first animal xenograft approved by ANVISA in Brazil. The method used in this study was an integrative literature review, with the aim of understanding the feasibility of using tilapia skin xenografts as a biological dressing for the treatment of burns, evaluating its efficacy and safety, conjecturing a possible use on a large scale in the SUS. It was verified the safety and applicability of the tilapia skin biological dressing as a treatment for burns and, with the emergence of new studies, the feasibility of its use in SUS becomes increasingly possible, verifying a good cost ratio-benefit.